comparemela.com

Latest Breaking News On - Chris viehbacher - Page 4 : comparemela.com

Biogen Inc (NASDAQ:BIIB) Q1 2024 Earnings Call Transcript

Biogen Inc. misses on earnings expectations. Reported EPS is $3.3 EPS, expectations were $3.45.

United statesEric schmidtSalveen richterAlisha alaimoChuck trianoPaul matteisChris viehbacherPriya singhalMike mcdonnellBiogen incCantor fitzgeraldGoldman sachsHead of developmentCall transcript aprilBiogen first quarterChief executive officer

Biogen tops profit estimates as cost cuts take hold, Alzheimer s drug Leqembi launch picks up

Alzheimer’s drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.

San diegoUnited statesChris viehbacherEisai leqembiEuropean unionWall streetReata pharmaceuticalsSage therapeutics

Biogen (BIIB) earnings Q1 2024

Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.

Eisai leqembiChris viehbacherWall street

Biogen (BIIB) Q1 2024 Earnings Call Transcript

BIIB earnings call for the period ending March 31, 2024.

United statesCzech republicMike mcdonnellPiper sandlerChris viehbacherSalveen richter goldman sachsMike yeeEric schmidt cantor fitzgeraldChris raymondTerence flynnAlisha alaimoPaul matteisSalveen richterMichael yeeJay olson oppenheimerChuck triano

To be better at neuroscience, Biogen will invest elsewhere

To be better at neuroscience, Biogen will invest elsewhere
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Chris viehbacherPriya singhalMichael mcdonnellBristol myers squibbKaruna therapeuticsFinancial officer michael mcdonnell

vimarsana © 2020. All Rights Reserved.